Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A, Luppi F, D'Amico R, Balduzzi S, Vicini R, Liverani A, Ruggieri V, Plebani M, Barbaro MP, Spanevello A, Canonica GW, Papi A, Fabbri LM, Beghè B; FARM58J2XH Study Group. Verduri A, et al. Among authors: fabbri lm. PLoS One. 2015 Mar 11;10(3):e0118241. doi: 10.1371/journal.pone.0118241. eCollection 2015. PLoS One. 2015. PMID: 25760346 Free PMC article. Clinical Trial.
Management of chronic refractory cough in adults.
Visca D, Beghè B, Fabbri LM, Papi A, Spanevello A. Visca D, et al. Among authors: fabbri lm. Eur J Intern Med. 2020 Nov;81:15-21. doi: 10.1016/j.ejim.2020.09.008. Epub 2020 Sep 19. Eur J Intern Med. 2020. PMID: 32958373 Free PMC article. Review.
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation).
Braido F, Melioli G, Cazzola M, Fabbri L, Blasi F, Moretta L, Canonica GW; AIACE Study Group. Braido F, et al. Pulm Pharmacol Ther. 2015 Aug;33:75-80. doi: 10.1016/j.pupt.2015.03.006. Epub 2015 May 5. Pulm Pharmacol Ther. 2015. PMID: 25951945 Clinical Trial.
Small airway dysfunction: not so silent after all?
Papi A, Morandi L, Fabbri L. Papi A, et al. Lancet Respir Med. 2020 Nov;8(11):1062-1063. doi: 10.1016/S2213-2600(20)30169-7. Epub 2020 Jun 26. Lancet Respir Med. 2020. PMID: 32598905 No abstract available.
Sarcoidosis: challenging diagnostic aspects of an old disease.
Spagnolo P, Luppi F, Roversi P, Cerri S, Fabbri LM, Richeldi L. Spagnolo P, et al. Among authors: fabbri lm. Am J Med. 2012 Feb;125(2):118-25. doi: 10.1016/j.amjmed.2011.06.003. Am J Med. 2012. PMID: 22269612 Free article. Review.
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G, Guasconi A, Montagna I, Vezzoli S, Petruzzelli S, Scuri M, Roche N, Singh D. Papi A, et al. Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.
440 results